Skip to main navigation

BioAtla, Inc logo

preloader
BioAtla, Inc logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Events and Presentations

Presentations

2024 Annual Shareholder Meeting 25.5 MB
Corporate Presentation – March 2026 5.1 MB

Past Events

11/13/25 at 4:30 PM EST
BioAtla Third Quarter 2025 Financial Results and Business Highlights Conference Call
Click here for webcast
8/7/25 at 4:30 PM EDT
BioAtla Second Quarter 2025 Financial Results and Business Highlights Conference Call
Click here for webcast
5/7/25 at 10:00 AM EDT
Citizens Life Sciences Conference
Click here for webcast
5/6/25 at 4:30 PM EDT
BioAtla First Quarter 2025 Financial Results and Business Highlights Conference Call
Click here for webcast
3/27/25 at 4:30 PM EDT
BioAtla Fourth Quarter 2024 Financial Results and Business Highlights Conference Call
Click here for webcast
11/7/24 at 4:30 PM EST
BioAtla Third Quarter 2024 Financial Results and Business Highlights Conference Call
Click here for webcast
9/9/24 at 7:00 AM EDT
H.C. Wainwright 26th Annual Global Investment Conference
Click here for webcast
8/8/24 at 4:30 PM EDT
BioAtla Second Quarter 2024 Financial Results and Business Highlights Conference Call
Click here for webcast
7/25/24 at 10:00 AM EDT
BioAtla R&D Day – July 25, 2024 10am ET
Click here for webcast
BioAtla R&D Day – July 2024 1.5 MB
6/5/24 at 8:00 AM EDT
BioAtla at Jefferies Global Healthcare Conference
Click here for webcast

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
logo-footer

BioAtla® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics™ (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer.

BIOATLA®

  • Technology
  • CAB Portfolio
  • Appendix

COMPANY

  • About
  • Team
  • Careers
  • News

LEGAL

  • Privacy Policy
  • Site Map
  • Expanded Access

GET IN TOUCH

  • Contact
  • Corporate Headquarters +1 858-558-0708

FOLLOW US

  • LinkedIn
  • Copyright © 2026 BioAtla®, Inc. All rights reserved